Table 1.
Definitions of primary endpoints
Endpoint | Definition | Comment |
---|---|---|
Death | Within one year after randomisation | |
Major complications: | ||
Intra-abdominal abscess | Fever or increased C reactive protein level/white blood cell count, or both, and intra-abdominal fluid collection on computed tomography or ultrasonography | Within 30 days after randomisation |
Pneumonia | Coughing or dyspnoea, radiography with infiltrative abnormalities, increased infection variable, and positive sputum culture result | Within 30 days after randomisation |
Myocardial infarction | Symptomatic increased cardiac enzyme levels and abnormalities on electrocardiography or cardiac ultrasonography | Within 30 days after randomisation |
Pulmonary embolism | Radiologically proven pulmonary embolism | Within 30 days after randomisation |
Need for reintervention | Surgical, endoscopic, or radiological reintervention | Within one year after randomisation. Before analysis, the adjudication committee decided to only report reinterventions directly or indirectly related to acute cholecystitis. A routine elective cholecystectomy after percutaneous catheter drainage was not included in the primary endpoint (ie, only cholecystectomies for recurrent gallstone related complications were included) |
Recurrent biliary disease | Within one year after randomisation. Before analysis, the adjudication committee decided to only report recurrent biliary disease when readmission was required |